Psychedelic substances have shown efficacy in research, clinical trials, underground therapy, ceremonial settings, and personal use as a treatment for anxiety. This includes social anxiety, especially in autistic adults, as well as end-of-life anxiety in patients facing terminal illness.
Things to Know
- Psilocybin is being studied in clinical research as a treatment for end-of-life anxiety in terminally ill patients
- The disruption of old thought patterns, coupled with new insights, neuroplasticity, increased emotional processing, increased sense of spirituality, and mystical experiences may help individuals overcome anxiety
LSD for Anxiety
Much of the research investigating LSD as a possible treatment for anxiety has focused on patients with terminal illness facing end-of-life anxiety.Read about LSD for anxiety.
Psilocybin Mushrooms for End-of-Life Anxiety
Many early studies looking at psilocybin for anxiety focus on treating end-of-life anxiety in patients with advanced-stage cancer.Read about psilocybin mushrooms for end-of-life anxiety.
MDMA for Anxiety
MDMA helps users feel more open and empathetic, greater pleasure, and a reduction in anxiety.Read about MDMA for anxiety.
MDMA for Social Anxiety in Autistic Adults
Research suggests MDMA may help alleviate social anxiety in autistic adults.Read about MDMA for social anxiety in autistic adults.
Ketamine for Anxiety
Ketamine research suggests it can help with symptoms of generalized anxiety disorder and social anxiety.Ketamine for anxiety.